HC Wainwright keeps Arrowhead Pharmaceuticals price target at $120.00
HC Wainwright & Co. maintained a $120.00/share price target for Arrowhead Pharmaceuticals, according to ratings actions reported by Benzinga via TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.